Introduction: Sputum and blood inflammatory markers, including MMP-9, TNFalpha and IL-8, are elevated in CF and these same biomarkers increase during pulmonary exacerbations. In this prospective study, we examine whether urinary inflammatory biomarkers are detectable and reflect clinical status in CF adults. Methods: Subjects were recruited at our regional centre, data included: demographics, spirometry and clinical status ('stable' or 'exacerbation'). Subjects were chronically infected with P. aeruginosa. Pulmonary exacerbations were defined according to the Fuchs criteria. Urinary MMP-9, TIMP-1, TIMP-2, neutrophil elastase, alpha-1-antitrypsin and neutrophil gelatinase-associated lipocalin (NGAL) were measured. Results: 14 subjects (8 male) had provided 24 urine samples at the time of abstract submission, FEV1% predicted (mean±SD) 49±14.2%. A1AT was significantly higher in 'stable ' compared to 'exacerbation' samples [535.0 (210.1-653 were significantly lower in 'stable' compared to 'exacerbation' samples. All other inflammatory markers tested were detected, but no significant differences were seen in this preliminary analysis.
139 Gamma delta IL-6, IL-12 correlate with FEV1 in children with cystic fibrosis The TIM family of membrane receptors have emerged as potential therapeutic targets to correct abnormal immune function in chronic inflammatory conditions. TIM-3 serves as a functional receptor in bronchial epithelial cells and through its natural ligand galectin-9 can modulate the inflammatory response. The aim of this study was to investigate whether TIM-3 was expressed in neutrophils and what function it may have in the healthy cell, which would be necessarily defective in the adult cystic fibrosis (CF) lung due to inactivation by neutrophil derived proteases. TIM-3 membrane expression in circulating neutrophils was examined using RT-PCR, western blotting and FACs analysis. Neutrophil degranulation was assessed by western blotting and superoxide (O − 2 ) production by cytochrome C reduction assays. Via signalling through TIM-3, galectin-9 induced neutrophil degranulation and O − 2 production. We have demonstrated that TIM-3 expressed on neutrophils plays a direct role in bacterial killing. Opsonisation of Pseudomonas aeruginosa with galectin-9 (50 nM) enhanced neutrophil-mediated bacterial killing by 25%, an effect abrogated by blockade of neutrophil TIM-3 receptors. This mechanism was gramnegative bacteria specific and mediated via galectin-9/lipopolysaccharide binding. In conclusion, our data suggest a novel role for TIM-3/galectin-9 in neutrophil function with important consequences in neutrophil mediated killing of Pseudomonas. However, in the CF lung, membrane TIM-3 and its ligand galectin-9 are proteolytically degraded, potentially contributing to the defective bacterial clearance observed within the CF lung despite the high neutrophilic presence.
